Resources

Magnesium sulfate is the most effective, low-cost treatment for preeclampsia/eclampsia, the second leading cause of maternal death in developing countries; yet it is widely underutilized. In this poster, created for the 2013 Saving Lives at Birth DevelopmentXChange, PATH proposed to develop a rectally delivered mucoadhesive gel containing magnesium sulfate. This will increase overall access to and the use of a critical anticonvulsant therapy for women with severe, life-threatening preeclampsia/eclampsia.

In 2012, project Optimize completed an assessment to explore the acceptability and feasibility of the innovative vaccine supply chain interventions the project had demonstrated in four collaborating countries. The goal was to learn about future implementations and to understand the current challenges and opportunities. This report describes the lessons learned.

This toolkit can help public health managers plan for the implementation of information and communications technology in health information systems. It draws on lessons learned by project Optimize, a five-year collaboration between the World Health Organization and PATH, to help optimize the vaccine supply chain. Find out more about PATH's work in digital health solutions.

This fact sheet from the Global Health Technologies Coalition outlines the FDA's role in global health and offers recommendations for how the FDA can continue to play an important role in efforts to ensure the safety of health tools to prevent, diagnose, and treat infectious diseases that affect millions of people worldwide every year.

Part of the Technology Updates series, this fact sheet describes PATH's work to develop a rapid, easy-to-read, low-cost test for Chagas disease.